- Home
- EWTX vs TAC Comparison
EWTX vs TAC Comparison
Compare EWTX & TAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EWTX | TAC |
|---|---|---|
| Founded | 2017 | 1909 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.2B |
| IPO Year | 2021 | 2001 |
Fundamental Metrics
Financial Performance| Metric | EWTX | TAC |
|---|---|---|
| Price | $43.29 | $12.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $39.00 | $23.67 |
| AVG Volume (30 Days) | ★ 1.2M | 1.1M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.57% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.69 | $11.38 |
| 52 Week High | $48.40 | $17.88 |
Technical Indicators
Market Signals| Indicator | EWTX | TAC |
|---|---|---|
| Relative Strength Index (RSI) | 52.02 | 44.13 |
| Support Level | $37.50 | $12.16 |
| Resistance Level | $44.93 | $13.06 |
| Average True Range (ATR) | 2.15 | 0.32 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 65.09 | 53.66 |
Price Performance
Historical ComparisonAbout EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.
About TAC TransAlta Corporation
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse electrical power generation assets in Canada, the United States, and Western Australia. The company has reportable segments namely, Hydro, Wind & Solar, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.